Clinical Trial: TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease

U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07295938) titled 'TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease' on Nov. 18.

Brief Summary: Chinese herbs can facilitate sputum culture conversion, promote lesion absorption, and enhance clinical symptoms and quality of life for patients with Mycobacterium abscessus pulmonary disease (MAB-PD). The investigators aimed to evaluate the efficacy of Chinese herbs as adjunct therapy to improve cure rates or reduce recurrence rates during the continuation phase of MAB-PD treatment.

Study Start Date: Sept. 08

Study Type: INTERVENTIONAL

Condition: Mycobacterium Abscessus Pulmonary Disease

Intervention: DRUG: Chinese herbs-I ...